Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.

Cochrane database of systematic reviews (Online)

Volumn , Issue 3, 2005, Pages

  Cody, J ^a   Daly, C ^a   Campbell, M ^a   Donaldson, C ^a   Khan, I ^a   Vale, L ^a   Wallace, S ^a   Macleod, A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; REVIEW;

ANEMIA; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN, RECOMBINANT; HEMATINICS; HUMANS; KIDNEY FAILURE, CHRONIC; RANDOMIZED CONTROLLED TRIALS; RENAL DIALYSIS;

EID: 32944460514     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (31)